市場調査レポート

商品コード

1098618

マラリアワクチンの市場規模・シェア・展望・機会 (2022年～2030年)：病原体・ワクチンタイプ・流通チャネル・地域別

Malaria Vaccines Market, by Agent, by Vaccine Type, by Distribution Channel and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

出版日: 2022年06月09日 | 発行: Coherent Market Insights

| ページ情報: 英文 166 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 4,500 700,920円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Multi User License)

USD 7,000 1,090,320円

レポートPDFを7名までにてご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は7回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise User License)

USD 10,000 1,557,600円

レポートPDFを同一企業およびその子会社のすべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=155.76円

全表示
概要
目次

概要

サンプル依頼リストに入れる

主要企業は契約などの成長戦略の採用に注力しており、予測期間中の世界のマラリアワクチン市場の成長を促進すると予測されています。

当レポートでは、世界のマラリアワクチンの市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、法規制環境、パイプラインの分析、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

Malaria is a life-threatening disease caused by parasites that are transmitted to people through the bites of infected female Anopheles mosquitoes. It is preventable and curable. Malaria vaccines are used to prevent the spread of malaria. The only approved vaccine, as of 2021, is RTS,S, known by the brand name Mosquirix. In October 2021, the World Health Organization (WHO) for the first time recommended the large-scale use of a malaria vaccine for children living in areas with moderate-to-high malaria transmission. Four injections of malaria vaccines are required for full protection.

Market Dynamics

Key players operating in the global malaria vaccine market are focusing on adoption of growth strategies such as agreements which are expected to drive market growth during the forecast period. For instance, in January 2021, GlaxoSmithKline (GSK), a science-led global healthcare company, PATH (Program for Appropriate Technology in Health), nonprofit global health organization based in Seattle, U.S., and Bharat Biotech (BBIL), is an Indian multinational biotechnology company announced the signing of a product transfer agreement for the malaria vaccine, RTS,S/AS01E. The agreement includes, transfer of manufacturing of the RTS,S antigen part of the vaccine and the grant of a license on all rights pertaining to the RTS,S/AS01 malaria vaccine to BBIL. GSK will retain the production of the adjuvant of the vaccine (AS01E) and will supply it to BBIL. Moreover, increasing research and development for malaria vaccine is expected to propel the global malaria vaccine market over the forecast period. For instance, in April 2021, scientists at the University of Oxford's Jenner Institute announced that their Phase IIb trial of a candidate malaria vaccine achieved 77% efficacy in early stage trials - making it the first malaria vaccine to meet the WHO's target of 75%. The Phase IIb trial of the vaccine candidate, R21, enrolled 450 children in Burkina Faso, one of the 10 countries with the highest cases of malaria and subsequent deaths.

Key features of the study:

This report provides in-depth analysis of the global malaria vaccine market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the Global Malaria vaccine Market based on the following parameters - Company Highlights, Products Portfolio, Key Highlights, Financial Performance, Strategies
Key companies covered as a part of this study include GlaxoSmithKline, Nobelpharma, Sanaria, CellFree Sciences, VLP Therapeutics LLC, Sumaya Biotech, BioNTech, and Precigen, Inc
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The Global Malaria vaccine Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global malaria vaccine market.

Detailed Segmentation:

Global Malaria vaccine Market, By Agent :
- Plasmodium Falciparum
- Plasmodium Vivax
- Anopheles Species
Global Malaria vaccine Market, By Vaccine Type :
- Pre-Erythrocytic
- Erythrocytic
- Multi-antigen
Global Malaria vaccine Market, By Distribution Channel :
- Public
- Private
Global Malaria vaccine Market, By Region:
- North America
  - By Country
  - U.S.
  - Canada
- Latin America
  - By Country
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
- Europe
  - By Country
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
- Asia Pacific
  - By Country
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - By Country
  - GCC
  - Israel
  - Rest of Middle East
- Africa
  - By Country
  - South Africa
  - Central Africa
  - North Africa
Company Profiles
- GlaxoSmithKline.*
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Nobelpharma
- Sanaria
- CellFree Sciences
- VLP Therapeutics LLC
- Sumaya Biotech
- BioNTech
- Precigen, Inc

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Agent
- Market Snapshot, By Vaccine Type
- Market Snapshot, By Distribution Channels
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunity
Impact Analysis
Regulatory Scenario
Market Trends
Pipeline Analysis
Key Developments
Epidemiology
PEST Analysis
Collaboration and Acquisition
Porters Analysis
Vaccine Developmental Cycle

4. Global Malaria Vaccines Market - Impact of Coronavirus (COVID-19) Pandemic

Economic Impact
Impact on Demand and Supply
COVID-19 Impact Assessments

5. Global Malaria Vaccines Market, By Agent, 2017-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Plasmodium Falciparum
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
Plasmodium Vivax
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
Anopheles Species
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)

6. Global Malaria Vaccines Market, By Vaccine Type, 2017-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Pre-Erythrocytic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
Erythrocytic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
Multi-antigen
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)

7. Global Malaria Vaccines Market, By Distribution Channel, 2017-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Public
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
Private
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)

8. Global Malaria Vaccines Market, By Region, 2017-2030, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Region, 2018-2030
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Agent, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn)
- U.S.
- Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Agent, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Agent, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn)
- U.K.
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Agent, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Agent, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn)
- GCC
- Israel
- Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Agent, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017-2030,(US$ Mn)
- North Africa
- Central Africa
- South Africa

9. Competitive Landscape

Heat Map Analysis
Market Share Analysis
- GlaxoSmithKline
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Nobelpharma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Sanaria
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- CellFree Sciences
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- VLP Therapeutics LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Sumaya Biotech
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- BioNTech
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Precigen, Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies

10. Section

Research Methodology
About us

マラリアワクチンの市場規模・シェア・展望・機会 (2022年～2030年)：病原体・ワクチンタイプ・流通チャネル・地域別

Malaria Vaccines Market, by Agent, by Vaccine Type, by Distribution Channel and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

目次

第1章調査目的・前提条件

第2章市場概要

第3章市場力学・規制・動向分析

第4章世界のマラリアワクチン市場：COVID-19の影響

第5章世界のマラリアワクチン市場：病原体別

第6章世界のマラリアワクチン市場：ワクチンタイプ別

第7章世界のマラリアワクチン市場：流通チャネル別

第8章世界のマラリアワクチン市場：地域別

第9章競合情勢

第10章セクション

Market Dynamics

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Malaria Vaccines Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Malaria Vaccines Market, By Agent, 2017-2030, (US$ Mn)

6. Global Malaria Vaccines Market, By Vaccine Type, 2017-2030, (US$ Mn)

7. Global Malaria Vaccines Market, By Distribution Channel, 2017-2030, (US$ Mn)

8. Global Malaria Vaccines Market, By Region, 2017-2030, (US$ Mn)

9. Competitive Landscape

10. Section

マラリアワクチンの市場規模・シェア・展望・機会 (2022年～2030年)：病原体・ワクチンタイプ・流通チャネル・地域別

Malaria Vaccines Market, by Agent, by Vaccine Type, by Distribution Channel and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

目次

第1章 調査目的・前提条件

第2章 市場概要

第3章 市場力学・規制・動向分析

第4章 世界のマラリアワクチン市場：COVID-19の影響

第5章 世界のマラリアワクチン市場：病原体別

第6章 世界のマラリアワクチン市場：ワクチンタイプ別

第7章 世界のマラリアワクチン市場：流通チャネル別

第8章 世界のマラリアワクチン市場：地域別

第9章 競合情勢

第10章 セクション

Market Dynamics

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Malaria Vaccines Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Malaria Vaccines Market, By Agent, 2017-2030, (US$ Mn)

6. Global Malaria Vaccines Market, By Vaccine Type, 2017-2030, (US$ Mn)

7. Global Malaria Vaccines Market, By Distribution Channel, 2017-2030, (US$ Mn)

8. Global Malaria Vaccines Market, By Region, 2017-2030, (US$ Mn)

9. Competitive Landscape

10. Section

第1章調査目的・前提条件

第2章市場概要

第3章市場力学・規制・動向分析

第4章世界のマラリアワクチン市場：COVID-19の影響

第5章世界のマラリアワクチン市場：病原体別

第6章世界のマラリアワクチン市場：ワクチンタイプ別

第7章世界のマラリアワクチン市場：流通チャネル別

第8章世界のマラリアワクチン市場：地域別

第9章競合情勢

第10章セクション